PKQuest Java: Free, interactive physiologically based pharmacokinetic software package and tutorial

BMC Research Notes

Volumn 2, Issue , 2009, Pages

  Levitt, David ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RATTUS;

EID: 77049088078     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-2-158     Document Type: Article

References (18)

1. Reddy MB Yang RSH, Clewell HJ 3rd Andersen ME, Physiologically Based Pharmacokinetic Modeling Hoboken, New Jersey: Wiley-Interscience 2005
2. Whole body physiologically-based pharmacokinetic models: their use in clinical drug development. Edginton AN Theil FP, Schmitt W Willmann S, Expert Opin Drug Metab Toxicol 2008 4 1143 1152 10.1517/17425255.4.9.1143 18721109
3. Physiologically based pharmacokinetics in drug development and regulatory science: a workshop report (Georgetown University, Washington, DC, May 2930, 2002). Rowland M Balant L Peck C, AAPS PharmSci 2004 6 6 10.1208/ps060106 15198507
4. Comparison of three physiologically-based pharmacokinetic models for the prediction of contrast agent distribution measured by dynamic MR imaging. Barboriak DP MacFall JR, Viglianti BL Dewhirst Dvm MW, J Magn Reson Imaging 2008 27 1388 1398 10.1002/jmri.21344 18504759
5. PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol. Levitt DG, BMC Clin Pharmacol 2002 2 5 10.1186/1472-6904-2-5 12182760
6. PKQuest: capillary permeability limitation and plasma protein binding application to human inulin, dicloxacillin and ceftriaxone pharmacokinetics. Levitt DG, BMC Clin Pharmacol 2002 2 7 10.1186/1472-6904-2-7 12323078
7. PKQuest: volatile solutes application to enflurane, nitrous oxide, halothane, methoxyflurane and toluene pharmacokinetics. Levitt DG, BMC Anesthesiol 2002 2 5 10.1186/1471-2253-2-5 12182764
8. PKQuest: measurement of intestinal absorption and first pass metabolism application to human ethanol pharmacokinetics. Levitt DG, BMC Clin Pharmacol 2002 2 4 10.1186/1472-6904-2-4 12182761
9. The use of a physiologically based pharmacokinetic model to evaluate deconvolution measurements of systemic absorption. Levitt DG, BMC Clin Pharmacol 2003 3 1 10.1186/1472-6904-3-1 12659643
10. The pharmacokinetics of the interstitial space in humans. Levitt DG, BMC Clin Pharmacol 2003 3 3 10.1186/1472-6904-3-3 12890292
11. Physiologically based pharmacokinetic modeling of arterial antecubital vein concentration difference. Levitt DG, BMC Clin Pharmacol 2004 4 2 10.1186/1472-6904-4-2 15053829
12. Heterogeneity of human adipose blood flow. Levitt DG, BMC Clin Pharmacol 2007 7 1 10.1186/1472-6904-7-1 17239252
13. Human physiologically based pharmacokinetic model for propofol. Levitt DG Schnider TW, BMC Anesthesiol 2005 5 4 10.1186/1471-2253-5-4 15847680
14. Human physiologically based pharmacokinetic model for ACE inhibitors: ramipril and ramiprilat. Levitt DG Schoemaker RC, BMC Clin Pharmacol 2006 6 1 10.1186/1472-6904-6-1 16398929
15. Prediction of human pharmacokinetics evaluation of methods for prediction of volume of distribution. Fagerholm U, J Pharm Pharmacol 2007 59 1181 1190 10.1211/jpp.59.9.0001 17883888 (Pubitemid 47359896)
16. The measurement of total body water in the human subject by deuterium oxide dilution. Schloerb PR Friis-Hansen BJ Edelman IS Solomon AK, Moore FD, J Clin Invest 1950 29 1296 1310 10.1172/JCI102366 14778892
17. On the incorporation of chemical-specific information in risk assessment. Clewell Iii HJ Andersen ME Blaauboer BJ, Toxicology Letters 2008 180 100 109 10.1016/j.toxlet.2008.06.002 18588959
18. Approaches for Applications of Physiologically Based Pharmacokinetic Models in Risk Assessment. Thompson CM Sonawane B, Barton HA DeWoskin RS, Lipscomb JC Schlosser P, Chiu WA Krishnan K, Taylor & Francis 2008 11 519 547